Ftse Mib
34.160,97
1,25%
DAX
19.984,32
0,74%
S&P 500
5.970,84
-1,11%
NASDAQ
19.722,03
-1,49%
Bitcoin
94.440,00
0,30%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Spruce Biosciences Inc (SPRB) Spruce Biosciences Inc (SPRB) Notizie

Spruce Biosciences Inc

SPRB
0,44
0,0097 (2,25%)
28 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/12/202423:15EDGAR2Form 8-K - Current report
21/12/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202402:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:08EDGAR2Form 8-K - Current report
10/12/202422:01BWSpruce Biosciences Announces Topline Results from..
14/11/202423:45EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202412:02EDGAR2Form 8-K - Current report
11/11/202414:00BWSpruce Biosciences Reports Third Quarter 2024 Financial..
28/10/202422:15EDGAR2Form 8-K - Current report
28/10/202421:01BWSpruce Biosciences to Participate in the Guggenheim..
03/9/202422:01BWSpruce Biosciences to Participate in the H.C. Wainwright..
12/8/202422:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202422:09EDGAR2Form 8-K - Current report
12/8/202422:01BWSpruce Biosciences Reports Second Quarter 2024 Financial..
18/6/202423:00EDGAR2Form 8-K - Current report
06/6/202414:00BWSpruce Biosciences Recognized as a Bay Area Best Place to..
05/6/202401:27BWスプルース・バイオサイエンスとHMNC Brain Health..
04/6/202422:16BWSpruce Biosciences und HMNC Brain Health kündigen..
04/6/202413:00BWSpruce Biosciences and HMNC Brain Health Announce Strategic..
03/6/202413:05EDGAR2Form 8-K - Current report
03/6/202413:00BWSpruce Biosciences Presented Phase 2 POWER Study Results of..
24/5/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:05EDGAR2Form 8-K - Current report
23/5/202422:05BWSpruce Biosciences to Participate in the Jefferies Global..
22/5/202422:14BWSpruce Biosciences Announces Poster Presentations at the..
13/5/202422:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:05EDGAR2Form 8-K - Current report
13/5/202422:01BWSpruce Biosciences Reports First Quarter 2024 Financial..
01/5/202422:05BWSpruce Biosciences to Participate in May Investor..
30/4/202422:05BWSpruce Biosciences Announces Additional Poster Presentation..
22/4/202422:05BWSpruce Biosciences Announces Upcoming Poster Presentation at..
13/3/202421:08BWSpruce Biosciences Reports Full Year 2023 Financial Results..
13/3/202421:01BWSpruce Biosciences Announces Topline Results from..
07/3/202422:07EDGAR2Form SC 13D/A - General statement of acquisition of..
06/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202422:05BWSpruce Biosciences to Present at the Oppenheimer 34th Annual..
22/1/202414:00BWSpruce Biosciences Completes Enrollment in CAHmelia-204..
08/1/202414:00EDGAR2Form 8-K - Current report
05/1/202414:00BWSpruce Biosciences Reports Baseline Characteristics from..
04/1/202414:00BWSpruce Biosciences Provides Clinical Program Updates and..
03/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,4263 Min: 0,4218 Max: 0,4518
Chiusura: 0,4303

La tua Cronologia

NASDAQ
SPRB
Spruce Biosciences
BIT
I10151
XS2803385751 20340531 19...
BIT
CP9
Exchange Traded
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network